Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
-10,07%
5-year Growth Rate
R
4/5
5-year Risk Analysis
O
-31,80%
Outlook 12/26
W
-129%
Margin of safety
T
N/A
Analyst Price Target
H
UP
50-week EMA Trend
Company Info
EPS Growth 5Y
29,07%
Revenue growth 5Y
-3,63%
Price growth 5Y
101,58%
Market Cap
HK$31,57 B
Long-Term Debt
HK$0,25 B
Annual earnings
03/31/2026 (A)
Dividend
HK$1,20
Dividend Yield
2,94%
Industry
Country
ISIN Number
Tianjin Pharmaceutical Da Ren Tang Group Corporation Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Tianjin Pharmaceutical Da Ren ...
SHSE:600329
|
135,73% | 101,58% | 34,15% | -10,07% | 4/5 | -31,80% | -129,02% | -100,00% | UP |
